Systematic review and network meta-analysis of the efficacy and safety of tumour necrosis factor inhibitor–methotrexate combination therapy versus triple therapy in rheumatoid arthritis

OBJECTIVE: Clinical trials have not consistently demonstrated differences between tumour necrosis factor inhibitor (TNFi) plus methotrexate and triple therapy (methotrexate plus hydroxychloroquine plus sulfasalazine) in rheumatoid arthritis (RA). The study objective was to estimate the efficacy, rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleischmann, Roy, Tongbram, Vanita, van Vollenhoven, Ronald, Tang, Derek H, Chung, James, Collier, David, Urs, Shilpa, Ndirangu, Kerigo, Wells, George, Pope, Janet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237767/
https://www.ncbi.nlm.nih.gov/pubmed/28123782
http://dx.doi.org/10.1136/rmdopen-2016-000371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237767/
https://www.ncbi.nlm.nih.gov/pubmed/28123782
http://dx.doi.org/10.1136/rmdopen-2016-000371

Ejemplares similares